Cassaday & Co Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.85M | Buy |
20,734
+144
| +0.7% | +$26.7K | 0.1% | 52 |
|
2025
Q1 | $4.31M | Sell |
20,590
-252
| -1% | -$52.8K | 0.12% | 42 |
|
2024
Q4 | $3.7M | Buy |
20,842
+75
| +0.4% | +$13.3K | 0.1% | 46 |
|
2024
Q3 | $4.1M | Sell |
20,767
-208
| -1% | -$41.1K | 0.12% | 40 |
|
2024
Q2 | $3.6M | Sell |
20,975
-98
| -0.5% | -$16.8K | 0.11% | 43 |
|
2024
Q1 | $3.84M | Buy |
21,073
+469
| +2% | +$85.4K | 0.12% | 42 |
|
2023
Q4 | $3.19M | Sell |
20,604
-272
| -1% | -$42.2K | 0.11% | 43 |
|
2023
Q3 | $3.11M | Sell |
20,876
-179
| -0.9% | -$26.7K | 0.13% | 39 |
|
2023
Q2 | $2.84M | Sell |
21,055
-85
| -0.4% | -$11.5K | 0.11% | 41 |
|
2023
Q1 | $3.37M | Sell |
21,140
-341
| -2% | -$54.3K | 0.14% | 36 |
|
2022
Q4 | $3.47M | Buy |
+21,481
| New | +$3.47M | 0.16% | 36 |
|